A blockbuster year could be building

Is biopharma about to have a very big year? If analysts are correct 22 potential blockbusters could be launched this year, consensus forecasts from Evaluate Pharma suggest, a level of productivity rivalled only by 2021, when pandemic approvals swelled the numbers.